Psychiatry & Neurology Doctors in Columbus, MS Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Raymond G Overstreet, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1001 Main St, Columbus, MS 39701 Phone: 662-328-9225    Fax: 662-328-4735

Dr. Richard Joseph Levitre, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 14th Medical Group 201 Independence Drive, Columbus, MS 39710 Phone: 662-434-2273

Saleem Akber Ali, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2520 Fifth Street North, Columbus, MS 39705 Phone: 662-244-2561    Fax: 662-244-2575

News Archive

State roundup: New Dem Gov. and Minn. Medicaid; Fla. docs on Medicaid changes; Iowa Gov. eyes long-term care loopholes; Conn. provider rates

Over the past decade, programs that integrate Medicaid and Medicare have resulted in improved consumer satisfaction, better health outcomes and lower Medicaid costs in Arizona, Massachusetts, Minnesota, New Mexico, New York, Wisconsin and Washington. In each case, states have had to change their Medicaid rules by attaining a waiver from the federal government (Vestal, 12/13).

Positive initial clinical data of IMGN901 used in combination regimen for multiple myeloma presented at ASH Annual Meeting

ImmunoGen, Inc., a biotechnology company that develops antibody-based anticancer products, today announced the presentation of positive initial clinical data with the Company's IMGN901 anticancer compound when used as part of a standard combination regimen to treat relapsed multiple myeloma.

Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment

Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.

CT colonography even safer than previously thought

The safety profile for CT colonography (CTC) is extremely favorable, particularly for the purposes of screening patients with no symptoms and when distending the colon using an automated carbon dioxide technique, a finding that goes against the higher complication rates for CTC reported by other groups, according to a new study.

St. Elizabeth Hospital meets Meaningful Use Stage 2 criteria with MEDITECH technology

Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services.

Read more Medical News

› Verified 4 days ago